Notably, while ADAM10 protein levels demonstrated an overall increase in CLL compared to healthy controls and a significant difference when compared to ALL, corresponding mRNA levels did not exhibit these distinctions. This evidence concerns the gene ADAM10 and acute lymphoblastic leukemia.